Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: The Cyprus Metabolism Prospective Cohort Study

Metabolism: Clinical and Experimental

Volumn 60, Issue 7, 2011, Pages 987-993

  Hamnvik, Ole Petter R ^a   Liu, Xiaowen ^b   Petrou, Michael ^c   Gong, Huizhi ^b   Chamberland, John P ^b   Kim, Esther H ^b   Christophi, Costas A ^c,d   Kales, Stefanos N ^d   Christiani, David C ^d   Mantzoros, Christos S ^d,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOLUBLE LEPTIN RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADIPOSITY; ADOLESCENT; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; HUMANS; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY; PROSPECTIVE STUDIES; RECEPTORS, LEPTIN; RISK FACTORS; SMOKING; WAIST-HIP RATIO; YOUNG ADULT;

EID: 79959357730     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.09.009     Document Type: Article

References (25)

1. Masuzaki H, Ogawa Y, Isse N, et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-8.
2. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5. (Pubitemid 26033933)
3. Kelesidis T, Kelesidis I, Chou S, et al. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010;152:93-100.
4. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413-37.
5. Hill RA, Margetic S, Pegg GG, et al. Leptin: its pharmacokinetics and tissue distribution. Int J Obes Relat Metab Disord 1998;22: 765-70. (Pubitemid 28359291)
6. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98:1277-82. (Pubitemid 26322051)
7. Lammert A, Kiess W, Bottner A, et al. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 2001;283:982-8. (Pubitemid 32924677)
8. Chan JL, Bluher S, Yiannakouris N, et al. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 2002;51:2105-12. (Pubitemid 34729014)
9. Sun Q, van Dam RM, Meigs JB, et al. Leptin and soluble leptin receptor levels in plasma and risk of Type 2 diabetes in US women: a prospective study. Diabetes 2010;59:611-8.
10. Ingelsson E, Larson MG, Yin X, et al. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 2008;93:3149-57.
11. Ogawa T, Hirose H, Yamamoto Y, et al. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism 2004;53:879-85. (Pubitemid 38829462)
12. Laimer M, Ebenbichler CF, Kaser S, et al. Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res 2002;10:597-601. (Pubitemid 135688257)
13. Tsao TH, Yang JB, Yang CB, et al. The soluble leptin receptor of regular exercisers. Int J Sports Med 2007;28:732-5. (Pubitemid 47414162)
14. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Accessed at http://www.idf.org/webdata/docs/ MetSyndrome-FINAL.pdf on 21 August 2010.
15. Lee CMY, Huxley RR, Wildman RP, et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008;61: 646-53.
16. Soderberg S, Zimmet P, Tuomilehto J, et al. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) 2007;31:1126-33. (Pubitemid 46987769)
17. Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010;53:600-5.
18. Huang L, Wang Z, Li C. Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 2001;276:6343-9.
19. Cohen SE, Kokkotou E, Biddinger SB, et al. High circulating leptin receptors with normal leptin sensitivity in liverspecific insulin receptor knock-out (LIRKO) mice. J Biol Chem 2007;282:23672-8. (Pubitemid 47311938)
20. Maamra M, Bidlingmaier M, Postel-Vinay MC, et al. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 2001;142: 4389-93. (Pubitemid 32907068)
21. Leung DW, Spencer SA, Cachianes G, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987;330:537-43. (Pubitemid 17164350)
22. Diez-Ruiz A, Tilz GP, Zangerle R, et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
23. Amit T, Youdim MB, Hochberg Z. Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function? J Clin Endocrinol Metab 2000;85:927-32.
24. Rogy MA, Coyle SM, Oldenburg HS, et al. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 1994;178:132-8. (Pubitemid 24073489)
25. Van Zee KJ, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845-9.